Found 6 matching trials
Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly PHASE3 Currently, the first line treatment for acromegaly is surgery, in order to ...
Show More Location
Multiple Locations
Learn More & Join Trial
Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide PHASE1 This study is designed to provide information on feasibility and reproducib...
Show More Location
Novartis Investigator Site
Learn More & Join Trial
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly PHASE4 This study will investigate the efficacy of a combination treatment with oc...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas PHASE4 The purpose of this study is to evaluate the efficacy of octreotide acetate...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut PHASE3 Placebo-controlled prospective randomized phase III study to investigate th...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Octreotide Efficacy and Safety in First-line Acromegalic Patients PHASE4 Primary Acromegaly is a clinical and metabolic disease caused by growth hor...
Show More Location
Novartis Investigative site
Learn More & Join Trial